Athira Pharma Inc

NASDAQ:ATHA  
9.19
+0.34 (+3.84%)
Earnings Announcements

Athira Pharma Reports Full Year 2021 Results

Published: 03/24/2022 20:17 GMT
Athira Pharma Inc (ATHA) - Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update.
Athira Pharma Inc- Cash, Cash Equivalents and Investments Were $319.7 Million As of December 31, 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.63

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.68

More details on our Analysts Page.